About Foncer Pharma
Foncer Pharma is a company. The company has 38 employees as of March 28, 2024. Foncer Pharma offers products and services including Vildafon-D and Fonelia P.
- Employees 38 as on 28 Mar, 2024
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
- Legal Name Foncer Pharma Pvt. Ltd
- Jurisdiction Nagpur, Maharashtra, India
-
Annual Revenue
$260.22 K (USD)213.48as on Mar 31, 2019
-
Net Profit
$7.47 K (USD)37.2as on Mar 31, 2019
-
EBITDA
$11.93 K (USD)36.5as on Mar 31, 2019
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
38
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Foncer Pharma
Foncer Pharma offers a comprehensive portfolio of products and services, including Vildafon-D and Fonelia P.
This product is utilized for the treatment of type 2 diabetes by regulating insulin and blood sugar levels
This service involves the combination of medications like Teneligliptin and Pioglitazone for managing diabetes effectively
Funding Insights of Foncer Pharma
Detailed funding history for Foncer Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Foncer Pharma
Investment portfolio details for Foncer Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Foncer Pharma
Detailed financials for Foncer Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Foncer Pharma Comparisons
Peer comparison for Foncer Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Foncer Pharma
Detailed competitors of Foncer Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Foncer Pharma
Complete news archive for Foncer Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Foncer Pharma
As of Mar 28, 2024, the latest employee count at Foncer Pharma is 38.
Annual revenue of Foncer Pharma is $260.22K as on Mar 31, 2019.
Foncer Pharma is known for its emphasis on continuous improvements in processes and systems to enhance the quality of pharmaceutical products and services. The company is engaged in procuring raw materials, preparing dossiers, and manufacturing products on a third-party basis to meet customer needs and boost satisfaction. Services are adapted to changing requirements, with a focus on providing high-standard formulations under the motto Caring for Better Health. Products are sourced and developed to promote health and happiness, ensuring effectiveness in quality management and delivery.
Foncer Pharma offers Vildafon-D and Fonelia P.